Charles P. McKenney

No open positions remaining

87 year

Health Technology

Retail Trade

Electronic Technology

Profile

Mr. Charles P.
McKenney is Independent Director at Arrowhead Research Corp.
He is on the Board of Directors at Arrowhead Research Corp., Unidym, Inc., Calando Pharmaceuticals, Inc., Ablaris Therapeutics, Inc., and Tego Biosciences Corp.
Mr. McKenney was previously employed as Attorney-Corporate Government Affairs by Sears, Roebuck & Co.

Former positions of Charles P. McKenney

Companies	Position	End
ARROWHEAD PHARMACEUTICALS, INC.	Director/Board Member	26/08/2015
Ablaris Therapeutics, Inc.	Director/Board Member	26/08/2015
Tego Biosciences Corp.	Director/Board Member	26/08/2015
Sears, Roebuck & Co. Sears, Roebuck & Co. Department StoresRetail Trade Operates department store chains	Corporate Officer/Principal	31/12/1988
Calando Pharmaceuticals, Inc. Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics	Director/Board Member	-

See the detail of Charles P. McKenney's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles P. McKenney's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Sears, Roebuck & Co. Sears, Roebuck & Co. Department StoresRetail Trade Operates department store chains	Retail Trade
Arrowhead Pharmaceuticals, Inc. Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases	Health Technology
Calando Pharmaceuticals, Inc. Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the design and development of drug-delivery-enhanced small molecule therapeutics	Health Technology
Unidym, Inc. Unidym, Inc. Electronic Production EquipmentElectronic Technology Develops and manufactures carbon nanotubes	Electronic Technology
Ablaris Therapeutics, Inc.
Tego Biosciences Corp.